
MK-677 (Ibutamoren)
Research Peptide | Lyophilized Powder | Batch Tested
For laboratory research use only. Not for human or animal consumption. Insulated shipping · Styrofoam box available.
Product Overview
MK-677 (Ibutamoren) is an orally active, non-peptide ghrelin-receptor agonist and growth-hormone secretagogue. Its oral bioavailability and long duration of action make it a convenient research tool for sustained stimulation of the GH/IGF-1 axis.
| Test | Result | Status |
|---|---|---|
| Purity | 99.0% | Passed ✓ |
Research Information
MK-677 is used to study once-daily, sustained activation of the GH/IGF-1 axis through ghrelin-receptor signaling in laboratory models. Research examines its effect on GH pulse amplitude, IGF-1 levels, appetite and sleep-related parameters, taking advantage of its oral, long-acting profile. Supplied strictly for in-vitro and laboratory research use only — not for human or animal consumption.
MK-677 (Ibutamoren) Research & Studies
What is MK-677 (Ibutamoren)?
MK-677 (Ibutamoren) is a non-peptide, orally active ghrelin-receptor agonist classified as a growth-hormone secretagogue. Laboratory research employs it to examine sustained stimulation of the GH/IGF-1 axis via ghrelin-receptor pathways. Its chemical structure supports oral bioavailability and a prolonged duration of action, making it a convenient tool for studying once-daily activation profiles in controlled experimental systems. Supplied exclusively for in-vitro and laboratory research use.
Mechanism of Action
MK-677 binds and activates the growth-hormone secretagogue receptor (GHS-R1a), the same receptor targeted by endogenous ghrelin. Receptor engagement triggers intracellular signaling cascades that promote pituitary growth-hormone release and subsequent elevation of circulating IGF-1 in model systems. Research focuses on how this non-peptide ligand produces sustained receptor occupancy compared with shorter-acting peptide secretagogues. Pathway studies also explore secondary effects on appetite-related and sleep-architecture markers within laboratory frameworks.
Primary Areas of Research
Investigators use MK-677 to probe once-daily, sustained activation of the GH/IGF-1 axis through ghrelin-receptor signaling. Key experimental endpoints include GH pulse amplitude, IGF-1 concentration dynamics, and associated metabolic parameters in cell-based and preclinical model systems. Additional research examines appetite-regulatory and sleep-related endpoints that accompany prolonged GHS-R1a agonism. The compound’s oral profile allows continuous dosing regimens that are difficult to achieve with injectable peptides.
Key Research Findings
Published laboratory work consistently demonstrates that MK-677 elevates GH secretion and raises IGF-1 levels through GHS-R1a-mediated pathways. Studies report amplification of GH pulse amplitude without major disruption of the underlying pulsatile pattern in experimental models. Research also documents concurrent changes in appetite-related and sleep-architecture markers under sustained receptor stimulation. These observations position MK-677 as a reference tool for dissecting long-acting ghrelin-mimetic pharmacology.
Research Handling & Considerations
MK-677 is supplied strictly for in-vitro and laboratory research use only and is not intended for human or animal consumption. Standard laboratory practices for handling non-peptide research compounds apply, including appropriate storage conditions to maintain chemical integrity. Researchers should consult material-safety data and institutional protocols when preparing solutions or conducting assays. All experimental designs must remain confined to controlled research environments.
Frequently Asked Questions
MK-677 acts as an agonist at the ghrelin receptor GHS-R1a, enabling studies of growth-hormone secretagogue signaling pathways.
Explore Other High-Purity Peptides

Ipamorelin

CJC-1295 (No DAC)

Sermorelin
